Department of Surgery, Washington University School of Medicine, Saint Louis, MO.
Department of Surgery, Washington University School of Medicine, Saint Louis, MO.
J Surg Res. 2021 Sep;265:212-222. doi: 10.1016/j.jss.2021.03.043. Epub 2021 May 2.
Sepsis induces gut barrier dysfunction characterized by increased gut epithelial apoptosis and increased intestinal permeability. The cytokine IL-22 has been demonstrated to regulate gut barrier function. Type-3 innate lymphoid cells (ILC3) are the predominate source of IL-22 in the GI tract. We hypothesized that sepsis may cause changes to the gut ILC3/IL-22 axis.
Sepsis was induced in WT and IL-22 KO mice by Pseudomonas aeruginosa pneumonia. Changes in gut-associated leukocyte populations were determined by flow-cytometry and ILC-associated transcripts were measured by RT-PCR. The effect of sepsis on gut permeability, pulmonary microbial burden, gut epithelial apoptosis, and survival was compared between WT and IL-22-/- mice.
Sepsis resulted in a significant decrease in the number of ILC3 in the gut, with a reciprocal increase in type-1 ILC (ILC1). Consistent with prior reports, sepsis was associated with increased gut permeability; however there was no difference in gut permeability, gut epithelial apoptosis, pulmonary microbial burden, or survival between WT and IL-22-/- mice.
Septic pneumonia causes a decrease in gut-associated ILC3 and an associated reciprocal increase in ILC1. This may reflect inflammation-induced conversion of ILC3 to ILC1. Constitutive systemic IL-22 deficiency does not alter sepsis-induced gut barrier dysfunction.
脓毒症可导致肠道屏障功能障碍,其特征为肠道上皮细胞凋亡增加和肠道通透性增加。细胞因子 IL-22 已被证明可调节肠道屏障功能。肠道中的先天淋巴细胞 3(ILC3)是 IL-22 的主要来源。我们假设脓毒症可能导致肠道 ILC3/IL-22 轴发生变化。
通过铜绿假单胞菌肺炎诱导 WT 和 IL-22 KO 小鼠发生脓毒症。通过流式细胞术确定肠道相关白细胞群的变化,并通过 RT-PCR 测量 ILC 相关转录物。比较 WT 和 IL-22-/-小鼠之间脓毒症对肠道通透性、肺部微生物负荷、肠道上皮细胞凋亡和存活率的影响。
脓毒症导致肠道中 ILC3 的数量显著减少,而 ILC1 的数量相应增加。与先前的报告一致,脓毒症与肠道通透性增加有关;然而,WT 和 IL-22-/-小鼠之间在肠道通透性、肠道上皮细胞凋亡、肺部微生物负荷或存活率方面没有差异。
脓毒症性肺炎导致肠道相关 ILC3 减少,同时 ILC1 相应增加。这可能反映了炎症诱导的 ILC3 向 ILC1 的转化。固有系统性 IL-22 缺乏不会改变脓毒症引起的肠道屏障功能障碍。